Larimar Therapeutics Inc (LRMR)
6.33
-0.13
(-2.01%)
USD |
NASDAQ |
Apr 25, 16:00
6.30
-0.03
(-0.47%)
After-Hours: 20:00
Larimar Therapeutics Price: 6.33 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 6.29 | 6.38 | 5.91 | 6.33 | 300998.0 |
Apr 24, 2024 | 6.48 | 6.50 | 6.32 | 6.46 | 222439.0 |
Apr 23, 2024 | 6.47 | 6.88 | 6.35 | 6.46 | 243953.0 |
Apr 22, 2024 | 6.53 | 6.56 | 6.19 | 6.40 | 238190.0 |
Apr 19, 2024 | 6.31 | 6.80 | 6.18 | 6.53 | 509318.0 |
Apr 18, 2024 | 6.96 | 7.00 | 6.330 | 6.38 | 510792.0 |
Apr 17, 2024 | 7.24 | 7.26 | 6.91 | 7.05 | 281333.0 |
Apr 16, 2024 | 7.22 | 7.37 | 7.07 | 7.24 | 397519.0 |
Apr 15, 2024 | 6.96 | 7.315 | 6.86 | 7.30 | 317536.0 |
Apr 12, 2024 | 7.12 | 7.17 | 6.79 | 6.96 | 219897.0 |
Apr 11, 2024 | 6.95 | 7.26 | 6.80 | 7.22 | 261744.0 |
Apr 10, 2024 | 6.91 | 7.09 | 6.79 | 6.84 | 490184.0 |
Apr 09, 2024 | 7.29 | 7.495 | 7.00 | 7.04 | 282247.0 |
Apr 08, 2024 | 7.35 | 7.69 | 7.20 | 7.22 | 355731.0 |
Apr 05, 2024 | 7.23 | 7.64 | 7.03 | 7.44 | 238048.0 |
Apr 04, 2024 | 7.74 | 7.98 | 7.17 | 7.27 | 365796.0 |
Apr 03, 2024 | 7.89 | 8.056 | 7.41 | 7.72 | 877602.0 |
Apr 02, 2024 | 7.30 | 7.385 | 7.03 | 7.36 | 395301.0 |
Apr 01, 2024 | 7.52 | 7.78 | 7.22 | 7.46 | 386168.0 |
Mar 28, 2024 | 7.28 | 8.065 | 7.19 | 7.59 | 515309.0 |
Mar 27, 2024 | 7.32 | 7.46 | 7.08 | 7.265 | 442161.0 |
Mar 26, 2024 | 7.65 | 7.72 | 7.20 | 7.20 | 522207.0 |
Mar 25, 2024 | 8.01 | 8.17 | 7.40 | 7.58 | 514406.0 |
Mar 22, 2024 | 8.56 | 8.64 | 8.09 | 8.09 | 781587.0 |
Mar 21, 2024 | 8.66 | 8.91 | 8.44 | 8.56 | 449006.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.53
Minimum
Aug 05 2022
32.28
Maximum
May 10 2019
9.490
Average
9.09
Median
Feb 09 2022
Price Benchmarks
Cogent Biosciences Inc | 6.01 |
ACADIA Pharmaceuticals Inc | 16.31 |
PTC Therapeutics Inc | 25.49 |
Renovaro Inc | 1.70 |
G1 Therapeutics Inc | 3.86 |
Price Related Metrics
Price to Book Value | 4.942 |
Earnings Yield | -13.27% |
Market Cap | 403.85M |